Spirulina Arthrospira platensis Gomont
Also called: Spirulina platensis, Arthrospira maxima, Spirulina maxima, blue-green algae, tecuitlatl
Spirulina is the dried biomass of Arthrospira platensis and A. maxima, cyanobacteria (blue-green algae) cultured in alkaline fresh water. It is about 65% to 70% protein and contains the blue pigment phycocyanin; a spirulina extract is an FDA-listed food color.
- Category
- Marine and algae
- Forms
- Whole dried biomass (powder, tablets); aqueous extract (phycocyanin color)
- Strongest evidence
- B Some positive trials
- Reviewed
- 2026-10-28
Class 1 Well studied in people. A 2025 meta-analysis (Nutr Metab) pooled 17 RCTs of spirulina in adults; it included only trials giving spirulina without any additional compound for at least 4 weeks. [9]
Fact-checked 2026-10-28 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
BHeart and blood vessels2 topics
CBlood sugar and weight1 topic
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Blood lipids in adults | B | 2023 meta-analysis of 20 trials (23 arms, 1,076 participants): spirulina lowered LDL cholesterol, total cholesterol and triglycerides (each SMD −0.6) and raised HDL (SMD 0.3). [3] |
| Blood pressure in adults | B | 2025 meta-analysis of RCTs: systolic −4.41 mmHg and diastolic −2.84 mmHg versus control, with substantial heterogeneity; authors rated certainty moderate and called for more high-quality trials. [4] |
| Body weight and body fat in adults | C | A 2025 meta-analysis of 17 RCTs found small reductions in body weight (-1.07 kg), BMI (-0.40) and body fat percentage (-0.84%), but no significant change in waist circumference. [9] |
Main constituents: Protein (about 65% to 70%), vitamins, minerals and phycocyanin [1]; Gamma-linolenic acid; calcium spirulan (a polysaccharide) [2]
Amounts studied and limits
Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.
- Doses in studies cited by LiverTox: 4.5 g daily; 6 g daily for 6 months; 500 mg twice daily for 12 weeks. [1]
No official upper intake level has been set.
Safety and side effects
- Liver (NIH LiverTox)Score DABCDEA: well known causeE: unlikely cause
LiverTox likelihood score D: possible rare cause of clinically apparent liver injury (chapter last updated April 10, 2019).
Details and sources - Pregnancy and breastfeedingLactMed: no data exist on excretion of spirulina components into breastmilk or on its safety in nursing mothers or infants …
1 statement in the profile.
Details and sources - Interactions with medicines1 listed
Drugs metabolized by CYP1A2 and CYP2E1
Details and sources - Cancer evaluations (IARC, NTP)1 found
Each names the exact material tested, which may differ from a supplement.
Details and sources - FDA new dietary ingredient notifications2 on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsNone found
No published information found in the sources checked.
Details and sources
- LiverTox likelihood score D (possible rare cause of clinically apparent liver injury). Controlled trials have not linked spirulina to liver enzyme elevations; the main case involved a man also taking other drugs that can injure the liver. [1]
- Spirulina can be contaminated with other blue-green algae (e.g., Microcystis species) that produce toxins; microcystins are liver toxins. Cyanotoxin contamination may cause liver and kidney failure, neurotoxicity, seizures and respiratory arrest. [2]
- Products grown in uncontrolled conditions can contain heavy metals and other contaminants. [5]
- Case reports: anaphylaxis; acute rhabdomyolysis in a 28-year-old man after one month; seizures with high blood calcium in a newborn whose mother took spirulina long term. [2]
- Minor effects include diarrhea, bloating, upset stomach, flatulence, edema, headache, muscle pain, facial flushing and sweating. No data exist on safety during breastfeeding. [5]
Interactions
| With | What happens |
|---|---|
| Drugs metabolized by CYP1A2 and CYP2E1 | Spirulina inhibits CYP1A2 and CYP2E1 and may raise levels of drugs metabolized by these enzymes; clinical relevance is not known. [2] |
Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.
Identity, quality and standardization
- In 2011 the US Pharmacopeia's expert committee reviewed 31 adverse event reports and assigned a Class A safety rating to Spirulina maxima and S. platensis, allowing quality monographs in USP-NF. [6]
- The FDA color additive spirulina extract must test negative for microcystin toxin and contain no more than 2 mg/kg lead, 2 mg/kg arsenic and 1 mg/kg mercury. [7]
- Blue-green algae products often contain Spirulina, Aphanizomenon flos-aquae (harvested from Upper Klamath Lake, Oregon), or both. [2]
- WoRMS lists Arthrospira platensis Gomont, 1892 as the accepted name. [8]
Regulatory status
- US: spirulina extract (filtered aqueous extract of dried Arthrospira platensis; coloring principle phycocyanins) is a color additive exempt from certification under 21 CFR 73.530, first listed in August 2013. Permitted uses include candy, beverages and coatings on dietary supplement tablets and capsules. [7]
- US: dietary supplements do not require extensive premarketing approval from the FDA; manufacturers are responsible for safety. [5]
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
US status
What FDA's published records show. FDA does not approve dietary supplements.
- FDA's published NDI notification list has 2 entries naming spirulina (Arthrospira), both in multi-ingredient combinations (earliest NDI 648 submitted 2010-04-07; most recent NDI 862 submitted 2015-02-12). Each entry is one party's notification; the list gives the date of FDA's response letter but not what it said. [P5]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
- No IARC carcinogenicity evaluation of spirulina (Arthrospira) was found (IARC Monographs list of classifications checked 2026-10-29). [P6]
- No NTP carcinogenicity technical report on spirulina (Arthrospira) or microcystins was found (NTP technical reports list checked 2026-10-29). [P8]
- IARC classifies microcystin-LR, a cyanobacterial toxin, as Group 2B (possibly carcinogenic to humans; Volume 94, 2010) and Microcystis extracts as Group 3. These are evaluations of the toxin and toxin-producing algae, not of spirulina; contamination of spirulina products with microcystin-producing algae is reported (see COA). [P6]
Liver (NIH LiverTox)
- LiverTox likelihood score D: possible rare cause of clinically apparent liver injury (chapter last updated April 10, 2019). LiverTox notes spirulina can be contaminated with other blue-green algae that produce toxins (microcystins). [P1]
Interactions with medicines
- Drugs metabolized by CYP1A2 and CYP2E1: MSK: spirulina inhibits CYP1A2 and CYP2E1 and may cause accumulation of drugs metabolized by these enzymes; clinical relevance is not known. [P2]
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- No published information found in the sources checked.
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity test of the dietary ingredient (at least one appropriate test or examination) — 21 CFR 111.75(a)(1)(i) requires at least one appropriate test or examination to verify the identity of any component that is a dietary ingredient, unless FDA grants an exemption petitioned under 111.75(a)(1)(ii). [P7]
- Microcystins (cyanotoxins) — Some products can be contaminated with Microcystis aeruginosa, which produces the hepatotoxins called microcystins. [P3]
- Heavy metals and other contaminants — Products grown in uncontrolled conditions can contain heavy metals and other contaminants. [P3]
- USP-NF quality monograph specifications (Spirulina maxima, S. platensis) — USP's Dietary Supplements Information Expert Committee assigned a Class A safety rating to Spirulina maxima and S. platensis, permitting admission of quality monographs in USP-NF. [P4]
Supply and conservation
- Spirulina is prepared from the biomass of blue-green algae; it typically grows in warm open lakes with high alkalinity. [P1]
Absorption in people
- No published information found in the sources checked.
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- No published information found in the sources checked.
Pregnancy and breastfeeding
- LactMed: no data exist on excretion of spirulina components into breastmilk or on its safety in nursing mothers or infants; breastmilk discoloration (green in one case) has been reported. [P3]
Sources for this profile
- NIH LiverTox (NIDDK). Spirulina (Last Update: April 10, 2019), 2019-04-10. ncbi.nlm.nih.gov
- Memorial Sloan Kettering Cancer Center. About Herbs: Blue-Green Algae (last updated June 5, 2023), 2023-06-05. mskcc.org
- Drugs and Lactation Database (LactMed). Spirulina (2021 Jun 21), 2021-06-21. pubmed.ncbi.nlm.nih.gov
- Marles RJ, et al. United States Pharmacopeia safety evaluation of spirulina. Crit Rev Food Sci Nutr. 2011;51(7):593-604, 2011-08. pubmed.ncbi.nlm.nih.gov
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- IARC Monographs. List of Classifications (agents classified by the IARC Monographs; checked 2026-10-29), 2026-10-29. monographs.iarc.who.int
- eCFR. 21 CFR 111.75 What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
- National Toxicology Program (NIEHS). Technical Reports list (checked 2026-10-29), 2026-10-29. ntp.niehs.nih.gov
Sources
- NIH LiverTox. Spirulina (last update April 10, 2019), 2019-04-10. ncbi.nlm.nih.gov
- Memorial Sloan Kettering Cancer Center. About Herbs: Blue-Green Algae (last updated June 5, 2023), 2023-06-05. mskcc.org
- Rahnama I, et al. The effect of Spirulina supplementation on lipid profile: GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials. Pharmacol Res 2023;193:106802, 2023-07. pubmed.ncbi.nlm.nih.gov
- Shiri H, et al. The effect of Spirulina supplementation on blood pressure in adults: a GRADE-assessed systematic review and meta-analysis of randomized clinical trials. Phytother Res 2025;39(1):397-412, 2025-01. pubmed.ncbi.nlm.nih.gov
- Drugs and Lactation Database (LactMed). Spirulina (2021 Jun 21), 2021-06-21. pubmed.ncbi.nlm.nih.gov
- Marles RJ, et al. United States Pharmacopeia safety evaluation of spirulina. Crit Rev Food Sci Nutr 2011;51(7):593-604, 2011-08. pubmed.ncbi.nlm.nih.gov
- eCFR. 21 CFR 73.530 Spirulina extract (current as of October 27, 2026), 2026-10-27. ecfr.gov
- WoRMS. Arthrospira platensis Gomont, 1892, AphiaID 213728 (accessed October 28, 2026). marinespecies.org
- Lak M, et al. Effects of spirulina supplementation on body composition in adults: a GRADE-assessed and dose-response meta-analysis of RCTs. Nutr Metab (Lond) 2025;22(1):61 (PMID 40528207), 2025-06-17. pubmed.ncbi.nlm.nih.gov
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in marine and algae: Astaxanthin · Bladderwrack · Carrageenan and agar · Chlorella · Dunaliella · Ecklonia cava · Fucoidan · Kelp and seaweed · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.